ABCC7 p.Ser1456Asn
Predicted by SNAP2: | A: N (78%), C: N (57%), D: D (59%), E: N (53%), F: N (53%), G: N (53%), H: N (57%), I: N (53%), K: N (57%), L: N (53%), M: N (61%), N: N (61%), P: D (59%), Q: N (66%), R: N (53%), T: N (61%), V: N (57%), W: D (59%), Y: N (61%), |
Predicted by PROVEAN: | A: N, C: N, D: N, E: N, F: N, G: N, H: N, I: N, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, T: N, V: N, W: N, Y: N, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Distribution of CFTR mutations in the Czech popula... J Cyst Fibros. 2013 Sep;12(5):532-7. doi: 10.1016/j.jcf.2012.12.002. Epub 2012 Dec 29. Krenkova P, Piskackova T, Holubova A, Balascakova M, Krulisova V, Camajova J, Turnovec M, Libik M, Norambuena P, Stambergova A, Dvorakova L, Skalicka V, Bartosova J, Kucerova T, Fila L, Zemkova D, Vavrova V, Koudova M, Macek M, Krebsova A, Macek M Jr
Distribution of CFTR mutations in the Czech population: positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations.
J Cyst Fibros. 2013 Sep;12(5):532-7. doi: 10.1016/j.jcf.2012.12.002. Epub 2012 Dec 29., [PMID:23276700]
Abstract [show]
BACKGROUND: This two decade long study presents a comprehensive overview of the CFTR mutation distribution in a representative cohort of 600 Czech CF patients derived from all regions of the Czech Republic. METHODS: We examined the most common CF-causing mutations using the Elucigene CF-EU2v1 assay, followed by MLPA, mutation scanning and/or sequencing of the entire CFTR coding region and splice site junctions. RESULTS: We identified 99.5% of all mutations (1194/1200 CFTR alleles) in the Czech CF population. Altogether 91 different CFTR mutations, of which 20 were novel, were detected. One case of de novo mutation and a novel polymorphism was revealed. CONCLUSION: The commercial assay achieved 90.7%, the MLPA added 1.0% and sequencing increased the detection rate by 7.8%. These comprehensive data provide a basis for the improvement of CF DNA diagnostics and/or newborn screening in our country. In addition, they are relevant to related Central European populations with lower mutation detection rates, as well as to the sizeable North American "Bohemian diaspora".
Comments [show]
None has been submitted yet.
No. Sentence Comment
51 In addition, 20 novel mutations (Table 1) and a novel variant (S1456N) were discovered.
X
ABCC7 p.Ser1456Asn 23276700:51:63
status: NEW57 Interestingly, the patient's asymptomatic father bears mutation S1455X in trans to a novel variant S1456N and the patient's apparently healthy brother has the maternal-F508del/S1456N genotype.
X
ABCC7 p.Ser1456Asn 23276700:57:99
status: NEWX
ABCC7 p.Ser1456Asn 23276700:57:176
status: NEW